RE:RE:RE:Fins on sedarBelow is email from German board. Translated to English if anyone interest in reading. We will see
I texted Jon Gluckman again. Answer: Thomas, I understand your concern, but the company is making as much progress as we can hope given the limited capital we have. As you may recall, we have contracted with Goldfields Group for their Brazil Lake lithium project in Yarmouth, Nova Scotia. We've made some very significant improvements in hard rock lithium processing, replacing toxic chemicals, reducing process complexity, and ultimately lowering capital and operating costs, while providing a clear path to on-site processing of battery-grade lithium carbonate have. This is practically unique in the lithium market and is attracting a lot of attention. We've had a very productive time at PDAC amplifying our commercialization efforts and have several additional mines evaluating test proposals or waiting for us to validate and advance with their ore. This also includes a follow-up order for the Brazil Lake project. Additionally, we have received additional interest and support from the Nova Scotia government to find ways to accelerate our efforts. We also have some interest in investing in the company to capitalize on the keen interest in lithium that currently exists. Please see the One Page Summary compiled by La Paid Capital who support us in our endeavours. Gold commercialization is still slow, but we are working on several potential deals. A key meeting of the Maryland Medical Cannabis Commission was held yesterday where we expect to have the final paperwork completed and approved for our first shipment of an Affinity. The deal with the licensed LP will be official at this point and we should be announcing that shortly, assuming the session goes as planned. Unfortunately it looks like our license deal with AESI will not materialize as they have not completed their exchange transaction with Hakken and thus the preconditions are not met and the letter of intent with them has expired. The good news is that we already have a replacement and are working on the details, but it will take a few more months. This will not impact our rollout plans. I'm also working on two potential licensing opportunities for the AMIPS pathogen technology
It is true that the company has a lot to achieve to recover from the situation we are in. Markets are still difficult and very conservative making it difficult to raise funds but we should be able to do so with more focus and an improved balance sheet and capitalization in the coming weeks. There's a lot going on and we're fighting like crazy. Please consider these emails as forward-looking statements as they represent our efforts, but as always there are no guarantees these efforts will be successful. Feel free to ask any other questions and I will do my best to answer them. BR Jon